Effect of Chinese Traditional Medicine for Post Revascularization Treatment of Coronary Artery Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

940 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-10-31

Study Completion Date

2009-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to built the standard of Chinese Traditional Medicine test for Post percutaneous coronary artery intervention and coronary artery bypass graft，also for acute coronary syndrome，according to the multi-site、random large sample test.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Treatment of Angina Pectoris After Coronary Revascularization With Integrated Traditional Chinese and Western Medicine

NCT05482009

Angina Pectoris

COMPLETED

Syndrome Differentiation in the Management of Chronic Stable Coronary Artery Disease (SCAD) to Improve Quality

NCT03018769

Chronic Stable Coronary Artery Disease

UNKNOWN

Effects of Integrated Treatment by Traditional Chinese and Western Medicine in Reducing Cardiovascular Events

NCT01715376

Angina Pectoris Coronary Artery Disease Coronary Disease +6 more

COMPLETED

Cohort Study on Treatment of Cardiovascular Diseases With Traditional Chinese Medicine

NCT05309343

Cardiovascular Diseases

RECRUITING

The Effect of Tongguan Capsule for MicroRNA Profiles in Coronary Heart Disease Patients

NCT02850627

Coronary Heart Disease Acute Myocardial Infarction

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Percutaneous Coronary Artery Intervention Coronary Artery Bypass Graft Acute Coronary Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

managed group

Group Type EXPERIMENTAL

cipher prescription 1

Intervention Type DRUG

Drug granules include ginseng,RADIX NOTOGINSENG,prepared RHIZOMA PINELLIAE with alumen radix glyrrhigae calcaren once daily for 180 days

control group

Group Type PLACEBO_COMPARATOR

cipher prescription 2

Intervention Type DRUG

Placebo include amidon、bitter principles and diluents bases once daily for 180 days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cipher prescription 1

Drug granules include ginseng,RADIX NOTOGINSENG,prepared RHIZOMA PINELLIAE with alumen radix glyrrhigae calcaren once daily for 180 days

Intervention Type DRUG

cipher prescription 2

Placebo include amidon、bitter principles and diluents bases once daily for 180 days

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age40～75
* angina or CAD patient
* deficiency of heart-QI and blockage of phlegm and blood stasis in chinese medicine
* 1 week after operation，or 1week after drainage tube extraction for CABG
* sign a informed consent

Exclusion Criteria

* severe cardia failure
* severe renal inadequacy
* complicating with malignant tumor,reactive alimentary tract hemorrhage and haematological systemic disorder etc.
* psychotic
* pregnant,lactation

Minimum Eligible Age

40 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No